Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127102881 | 12710288 | 1 | I | 20160504 | 20160819 | 20160902 | 20160902 | EXP | GB-MHRA-TPP15049677C2217697YC1470766518175 | GB-TEVA-687459ACC | TEVA | 40.00 | YR | M | Y | 83.00000 | KG | 20160902 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127102881 | 12710288 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 1000 MILLIGRAM DAILY; | 54958.3333 | MG | U | U | 74124 | 500 | MG | BID | |||
| 127102881 | 12710288 | 2 | C | ALZAIN | 2 | 2 DOSAGE FORMS DAILY; | 94 | DF | 0 | 1 | DF | BID | |||||||
| 127102881 | 12710288 | 3 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 1 DOSAGE FORMS DAILY; | 6 | DF | 0 | 1 | DF | QD | ||||||
| 127102881 | 12710288 | 4 | C | DERMOL | BENZALKONIUM CHLORIDECHLORHEXIDINE HYDROCHLORIDEISOPROPYL MYRISTATEPARAFFIN | 1 | 1 DOSAGE FORMS DAILY; 1 DOSAGE FORM, FOR WASHING. | 721 | DF | 0 | 1 | DF | QD | ||||||
| 127102881 | 12710288 | 5 | C | PREGABALIN. | PREGABALIN | 1 | 2 DOSAGE FORMS DAILY; | 58 | DF | 0 | 1 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127102881 | 12710288 | 1 | Prostatitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127102881 | 12710288 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127102881 | 12710288 | Abdominal pain | |
| 127102881 | 12710288 | Arthralgia | |
| 127102881 | 12710288 | Bradyphrenia | |
| 127102881 | 12710288 | Constipation | |
| 127102881 | 12710288 | Dermatitis contact | |
| 127102881 | 12710288 | Dyspnoea | |
| 127102881 | 12710288 | Fatigue | |
| 127102881 | 12710288 | Feeling abnormal | |
| 127102881 | 12710288 | Hair colour changes | |
| 127102881 | 12710288 | Heart rate increased | |
| 127102881 | 12710288 | Inguinal mass | |
| 127102881 | 12710288 | Insomnia | |
| 127102881 | 12710288 | Joint stiffness | |
| 127102881 | 12710288 | Malaise | |
| 127102881 | 12710288 | Muscle twitching | |
| 127102881 | 12710288 | Nausea | |
| 127102881 | 12710288 | Night sweats | |
| 127102881 | 12710288 | Palpitations | |
| 127102881 | 12710288 | Rash | |
| 127102881 | 12710288 | Suicidal ideation | |
| 127102881 | 12710288 | Vision blurred | |
| 127102881 | 12710288 | Vitreous floaters |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127102881 | 12710288 | 1 | 20160310 | 0 | ||
| 127102881 | 12710288 | 2 | 20160620 | 0 | ||
| 127102881 | 12710288 | 3 | 20160510 | 20160607 | 0 | |
| 127102881 | 12710288 | 4 | 20140514 | 0 | ||
| 127102881 | 12710288 | 5 | 20160602 | 20160603 | 0 |